AAPL340.08+3.17 (+0.94%) ▲|ABBV263.20+6.29 (+2.45%) ▲|ABT107.27+2.78 (+2.66%) ▲|ACN164.66+10.60 (+6.88%) ▲|ADBE249.18+11.43 (+4.81%) ▲|AMAT476.46-40.43 (-7.82%) ▼|AMD454.62-40.33 (-8.15%) ▼|AMGN393.10+16.84 (+4.48%) ▲|AMT171.50+4.76 (+2.85%) ▲|AMZN230.86-0.53 (-0.23%) ▼|AVGO380.91-2.31 (-0.60%) ▼|AXP336.63+1.24 (+0.37%) ▲|BA221.56+10.06 (+4.76%) ▲|BAC62.62+0.49 (+0.79%) ▲|BKNG199.31+12.52 (+6.70%) ▲|BLK1,097.55+35.41 (+3.33%) ▲|BMY63.60+1.04 (+1.66%) ▲|BNY156.49-1.28 (-0.81%) ▼|BRK-B512.37+15.19 (+3.06%) ▲|C132.47-0.63 (-0.47%) ▼|CAT840.85-32.43 (-3.71%) ▼|CL92.73+0.75 (+0.82%) ▲|CMCSA24.19+1.39 (+6.10%) ▲|COF212.41+5.36 (+2.59%) ▲|COP114.10-1.48 (-1.28%) ▼|COST966.58+15.00 (+1.58%) ▲|CRM181.50+7.90 (+4.55%) ▲|CSCO115.58+1.01 (+0.88%) ▲|CVS109.34+2.27 (+2.12%) ▲|CVX187.58-2.42 (-1.27%) ▼|DE639.84+14.82 (+2.37%) ▲|DHR199.05+2.55 (+1.30%) ▲|DIS98.89+2.24 (+2.32%) ▲|DUK129.24+0.41 (+0.32%) ▲|EMR151.81+2.51 (+1.68%) ▲|FDX312.64+1.85 (+0.60%) ▲|GD393.19+4.05 (+1.04%) ▲|GE363.59+1.98 (+0.55%) ▲|GEV943.38-53.19 (-5.34%) ▼|GILD134.32+3.80 (+2.91%) ▲|GM90.30+3.26 (+3.75%) ▲|GOOG332.60+6.03 (+1.85%) ▲|GOOGL333.71+7.15 (+2.19%) ▲|GS1,033.34-14.89 (-1.42%) ▼|HD344.47+8.38 (+2.49%) ▲|HON247.05+1.30 (+0.53%) ▲|IBM227.55+11.27 (+5.21%) ▲|INTC86.30-5.37 (-5.86%) ▼|INTU312.99+9.08 (+2.99%) ▲|ISRG361.80+4.97 (+1.39%) ▲|JNJ266.73+0.78 (+0.29%) ▲|JPM357.31+1.11 (+0.31%) ▲|KO88.27+4.20 (+5.00%) ▲|LIN511.18+4.16 (+0.82%) ▲|LLY1,220.66+23.13 (+1.93%) ▲|LMT581.31+1.31 (+0.23%) ▲|LOW218.24+6.69 (+3.16%) ▲|LRCX269.61-22.00 (-7.54%) ▼|MA562.75+11.04 (+2.00%) ▲|MCD273.02+2.35 (+0.87%) ▲|MDLZ62.48+1.81 (+2.98%) ▲|MDT86.88+2.66 (+3.16%) ▲|META593.41-0.46 (-0.08%) ▼|MMM182.48+4.25 (+2.38%) ▲|MO74.82+1.93 (+2.65%) ▲|MRK131.82+1.06 (+0.81%) ▲|MS211.58-2.98 (-1.39%) ▼|MSFT393.35+4.25 (+1.09%) ▲|MU820.53-79.67 (-8.85%) ▼|NEE89.28+0.45 (+0.51%) ▲|NFLX72.39+1.99 (+2.83%) ▲|NKE43.05+0.91 (+2.16%) ▲|NOW110.62+5.06 (+4.79%) ▲|NVDA197.01+0.50 (+0.25%) ▲|ORCL119.96+0.06 (+0.05%) ▲|PEP142.86+3.07 (+2.20%) ▲|PFE25.25+0.58 (+2.35%) ▲|PG148.88+0.25 (+0.17%) ▲|PLTR123.53-8.00 (-6.08%) ▼|PM200.17+4.51 (+2.31%) ▲|QCOM162.88-7.16 (-4.21%) ▼|RTX218.58+0.16 (+0.07%) ▲|SBUX103.10-0.55 (-0.53%) ▼|SCHW105.97+1.79 (+1.72%) ▲|SO96.78+0.30 (+0.31%) ▲|SPG236.70+5.03 (+2.17%) ▲|T24.66+0.24 (+0.98%) ▲|TMO576.41+16.88 (+3.02%) ▲|TMUS182.39+5.18 (+2.92%) ▲|TSLA307.44-1.78 (-0.58%) ▼|TXN277.07-2.34 (-0.84%) ▼|UBER70.74+2.56 (+3.75%) ▲|UNH428.79+11.15 (+2.67%) ▲|UNP294.45-4.85 (-1.62%) ▼|UPS105.53-7.42 (-6.57%) ▼|USB64.43+0.94 (+1.48%) ▲|V366.59+4.06 (+1.12%) ▲|VZ48.19+0.87 (+1.84%) ▲|WFC86.87-0.40 (-0.46%) ▼|WMT113.10+1.36 (+1.22%) ▲|XOM153.04-1.73 (-1.12%) ▼|AAPL340.08+3.17 (+0.94%) ▲|ABBV263.20+6.29 (+2.45%) ▲|ABT107.27+2.78 (+2.66%) ▲|ACN164.66+10.60 (+6.88%) ▲|ADBE249.18+11.43 (+4.81%) ▲|AMAT476.46-40.43 (-7.82%) ▼|AMD454.62-40.33 (-8.15%) ▼|AMGN393.10+16.84 (+4.48%) ▲|AMT171.50+4.76 (+2.85%) ▲|AMZN230.86-0.53 (-0.23%) ▼|AVGO380.91-2.31 (-0.60%) ▼|AXP336.63+1.24 (+0.37%) ▲|BA221.56+10.06 (+4.76%) ▲|BAC62.62+0.49 (+0.79%) ▲|BKNG199.31+12.52 (+6.70%) ▲|BLK1,097.55+35.41 (+3.33%) ▲|BMY63.60+1.04 (+1.66%) ▲|BNY156.49-1.28 (-0.81%) ▼|BRK-B512.37+15.19 (+3.06%) ▲|C132.47-0.63 (-0.47%) ▼|CAT840.85-32.43 (-3.71%) ▼|CL92.73+0.75 (+0.82%) ▲|CMCSA24.19+1.39 (+6.10%) ▲|COF212.41+5.36 (+2.59%) ▲|COP114.10-1.48 (-1.28%) ▼|COST966.58+15.00 (+1.58%) ▲|CRM181.50+7.90 (+4.55%) ▲|CSCO115.58+1.01 (+0.88%) ▲|CVS109.34+2.27 (+2.12%) ▲|CVX187.58-2.42 (-1.27%) ▼|DE639.84+14.82 (+2.37%) ▲|DHR199.05+2.55 (+1.30%) ▲|DIS98.89+2.24 (+2.32%) ▲|DUK129.24+0.41 (+0.32%) ▲|EMR151.81+2.51 (+1.68%) ▲|FDX312.64+1.85 (+0.60%) ▲|GD393.19+4.05 (+1.04%) ▲|GE363.59+1.98 (+0.55%) ▲|GEV943.38-53.19 (-5.34%) ▼|GILD134.32+3.80 (+2.91%) ▲|GM90.30+3.26 (+3.75%) ▲|GOOG332.60+6.03 (+1.85%) ▲|GOOGL333.71+7.15 (+2.19%) ▲|GS1,033.34-14.89 (-1.42%) ▼|HD344.47+8.38 (+2.49%) ▲|HON247.05+1.30 (+0.53%) ▲|IBM227.55+11.27 (+5.21%) ▲|INTC86.30-5.37 (-5.86%) ▼|INTU312.99+9.08 (+2.99%) ▲|ISRG361.80+4.97 (+1.39%) ▲|JNJ266.73+0.78 (+0.29%) ▲|JPM357.31+1.11 (+0.31%) ▲|KO88.27+4.20 (+5.00%) ▲|LIN511.18+4.16 (+0.82%) ▲|LLY1,220.66+23.13 (+1.93%) ▲|LMT581.31+1.31 (+0.23%) ▲|LOW218.24+6.69 (+3.16%) ▲|LRCX269.61-22.00 (-7.54%) ▼|MA562.75+11.04 (+2.00%) ▲|MCD273.02+2.35 (+0.87%) ▲|MDLZ62.48+1.81 (+2.98%) ▲|MDT86.88+2.66 (+3.16%) ▲|META593.41-0.46 (-0.08%) ▼|MMM182.48+4.25 (+2.38%) ▲|MO74.82+1.93 (+2.65%) ▲|MRK131.82+1.06 (+0.81%) ▲|MS211.58-2.98 (-1.39%) ▼|MSFT393.35+4.25 (+1.09%) ▲|MU820.53-79.67 (-8.85%) ▼|NEE89.28+0.45 (+0.51%) ▲|NFLX72.39+1.99 (+2.83%) ▲|NKE43.05+0.91 (+2.16%) ▲|NOW110.62+5.06 (+4.79%) ▲|NVDA197.01+0.50 (+0.25%) ▲|ORCL119.96+0.06 (+0.05%) ▲|PEP142.86+3.07 (+2.20%) ▲|PFE25.25+0.58 (+2.35%) ▲|PG148.88+0.25 (+0.17%) ▲|PLTR123.53-8.00 (-6.08%) ▼|PM200.17+4.51 (+2.31%) ▲|QCOM162.88-7.16 (-4.21%) ▼|RTX218.58+0.16 (+0.07%) ▲|SBUX103.10-0.55 (-0.53%) ▼|SCHW105.97+1.79 (+1.72%) ▲|SO96.78+0.30 (+0.31%) ▲|SPG236.70+5.03 (+2.17%) ▲|T24.66+0.24 (+0.98%) ▲|TMO576.41+16.88 (+3.02%) ▲|TMUS182.39+5.18 (+2.92%) ▲|TSLA307.44-1.78 (-0.58%) ▼|TXN277.07-2.34 (-0.84%) ▼|UBER70.74+2.56 (+3.75%) ▲|UNH428.79+11.15 (+2.67%) ▲|UNP294.45-4.85 (-1.62%) ▼|UPS105.53-7.42 (-6.57%) ▼|USB64.43+0.94 (+1.48%) ▲|V366.59+4.06 (+1.12%) ▲|VZ48.19+0.87 (+1.84%) ▲|WFC86.87-0.40 (-0.46%) ▼|WMT113.10+1.36 (+1.22%) ▲|XOM153.04-1.73 (-1.12%) ▼|
24 C
New York
Wednesday, July 29, 2026

Tag: revenues

newssourceFORcompanyinformationcontent1releasesmarket

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others. 
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

Reitmans (Canada) Limited Reports First Quarter Financial Results

Net revenues from retail stores up 2.9% on lower store count MONTREAL, June 16, 2026 /CNW/ - Reitmans (Canada) Limited ("RCL" or the "Company")...

Mondelēz International Announces Nine Start-Ups Chosen to Participate in CoLab Tech 2026 Program

CHICAGO, June 16, 2026 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) today announced the nine companies selected for CoLab Tech 2026. This is the third cohort to participate in the snack company’s accelerator program, led by its global research and development team.

Verizon Breaks Industry Mold to Put Customers First

Introduces Industry-First Loyalty Program for All Customers with Cash Back in Verizon Dollars, Daily Surprises, and the End of Device Upgrade and Activation Fees

OLIN and HUNTSMAN Announce Transformative Merger of Equals to Create a $12+ Billion Integrated North American Chemicals Leader

Complementary upstream and downstream capabilities to enhance integration and enable the combined company to better create value across cycles, products and regions $400+ million...

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

Hybar Announces Pricing of $400,000,000 of Senior Secured Green Notes

OSCEOLA, Ark., June 15, 2026 /PRNewswire/ -- Hybar LLC ("Hybar") announced today the pricing of the previously announced offering (the "Offering") of $400,000,000 aggregate...

Mondelēz International Names Amit Banati Executive Vice President and Chief Financial Officer

CHICAGO, June 15, 2026 (GLOBE NEWSWIRE) -- Mondelēz International (Nasdaq: MDLZ) today announced the appointment of Amit Banati as Executive Vice President and Chief Financial Officer, effective July 1, 2026. He will report directly to Dirk Van de Put, Chair and Chief Executive Officer, and will be a member of the Mondelēz International Leadership Team. Following Banati’s appointment, Luca Zaramella will continue as Executive Vice President and Chief Operating Officer, focusing his leadership on the Company’s commercial operations, including its four geographical regions, corporate sales, marketing and supply chain functions.

Bio-Based Cosmetics and Personal Care Ingredients Market Size/Share Worth USD 18.93 Billion by 2035 at a 11.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Bio-Based Cosmetics and Personal Care Ingredients Market size & share revenue was valued at approximately USD 5.84 Billion in 2025 and is expected to reach USD 6.62 Billion in 2026 and is expected to reach around USD 18.93 Billion by 2035, at a CAGR of 11.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Givaudan SA, Firmenich SA (dsm-firmenich), Symrise AG, Croda International Plc, Evonik Industries AG, BASF SE, Clariant AG, Ashland Global Holdings Inc., Elementis plc, Innospec Inc. and others. 
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Bio-Based Cosmetics and Personal Care Ingredients Market size & share revenue was valued at approximately USD 5.84 Billion in 2025 and is expected to reach USD 6.62 Billion in 2026 and is expected to reach around USD 18.93 Billion by 2035, at a CAGR of 11.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Givaudan SA, Firmenich SA (dsm-firmenich), Symrise AG, Croda International Plc, Evonik Industries AG, BASF SE, Clariant AG, Ashland Global Holdings Inc., Elementis plc, Innospec Inc. and others.

International Petroleum Corporation Corporate Update: Blackrod Phase 1 First Oil Achieved

TORONTO, June 15, 2026 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce first oil has been achieved at Phase 1 of the Blackrod project, ahead of schedule and on budget.

International Petroleum Corporation Corporate Update: Blackrod Phase 1 First Oil Achieved

International Petroleum Corporation (IPC) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce first oil has been achieved at Phase 1 of the Blackrod project, ahead of schedule and on budget.

/C O R R E C T I O N — Kootenay Silver Inc./

In the news release, Kootenay Silver Announces Positive PEA with a US$763 Million After-Tax NPV & 41% IRR for La Cigarra Silver Project, issued...

Press release: Orange issues 850 million euros of hybrid notes

Press release
Paris, 15 June 2026

Gazexport Limited Raises Shareholder Concerns Regarding Loss of Akkulkovskoye Oil Field License

Gazexport Limited raises shareholder concerns regarding the loss of the Akkulkovskoye oil field license in Kazakhstan.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRevenues

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers